Giulia Petroni, PhD
Post-Doctoral Associate
Apr 2019 – Jan 2022

(Co)-first Authored Publications

  1. Petroni, G., Buqué, A., Coussens L.M. and L. Galluzzi. Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nat Rev Drug Discov, 2022. 22(6): p. 440-462.
  2. Petroni, G., Cantley, L.C., Santambrogio, L., Formenti, S.C. and L. Galluzzi. Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nat Rev Clin Oncol, 2022.  19(2): p. 114-131.
  3. Petroni, G., Buqué, A., Yamazaki, T. et al. Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer. Clin Cancer Res, 2021. 27(7): p. 1855-1863.
  4. Petroni, G., Buqué, A., Zitvogel, L., Kroemer, G. and L. Galluzzi. Immunomodulation by targeted anticancer agents. Cancer Cell, 2021. 39(3): p. 310-345.
  5. Petroni, G., Kroemer, G. and L. Galluzzi. Immunogenic therapies drive CAR T cells towards superior efficacy. Trends Cancer, 2021. 7(3): p. 179-181.
  6. Petroni, G. and L. Galluzzi. Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents. Oncoimmunology, 2021. 10(1): p. 1889101.
  7. Petroni, G., Vitale, I. and L. Galluzzi. Caspase 2 and p53 reunited in tumor control. Trends Cell Biol, 2020. 30(12): p. 917-918.
  8. Petroni, G., Formenti, S.C., Chen-Kiang, S. and L. Galluzzi. Immunomodulation by anticancer cell cycle inhibitors. Nat Rev Immunol, 2020. 20(11): p. 669-679.
  9. Petroni, G. and L. Galluzzi. Senescence inflames the pancreatic tumor Microenvironment. Cell Rep Med, 2020. 1(2): p. 100020.
  10. Petroni, G. and L. Galluzzi. Cancer immunotherapy with CDK7 inhibitors. Trends Cancer, 2020. 6(5): p. 361-363.

(Co)-senior Authored Publications

  1. Klapp, V., Buqué, A., Bloy, N. et al. Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors. J Transl Med, 2023. 21: p. 110.
  2. Jiménez-Cortegana, C., Klapp, V., Bloy, N. et al. Cytofluorometric assessment of cell cycle progression in irradiated cells. Methods Cell Biol, 2022. 172: p. 1-16.

Abstracts selected for Oral Presentation (First/co-first and last/co-last only)

  1. Petroni, G. Anti-tumor immune response following treatment with cell cycle inhibitors and radiation therapy. 1st Onco-Immunology Conference Day (Virtual, February 2021).
  2. Petroni, G., Gouin, K., Buquè, A. et al. Immunological mechanisms of resistance to CDK4/CDK6 inhibitors in breast cancer. 1st Paris Immuno-Oncology Conference (Paris, France, July 2021).

Abstracts Selected for Poster Presentation (First/co-first and last/co-last only)

  1. Petroni, G., Gouin, K., Buquè, A. et al. Immunological mechanisms of resistance to CDK4/CDK6 inhibitors in breast cancer. 36th Annual SITC Meeting (Washington, D.C., US, November 2021).
  2. Petroni, G., Di Liberto, M., Buquè, A. et al. Radiation therapy as a tool to sensitize HR+ breast cancer and mantle cell lymphoma to CDK4/6 inhibitors. AACR Virtual Annual Meeting 2020 (Virtual, April and June 2020).
  3. Petroni, G., Buquè, A., Di Liberto, M., et al. Radiation therapy as a tool to optimize immunomodulation by cell cycle inhibitors in HR+ breast cancer. 34th Annual SITC Meeting (Washington, D.C., US, November 2019).

Fellowships

  1. Post-Doctoral Fellowship (2019) funded by Fondazione Umberto Veronesi (Italy). 

Other achievements

  1. William Guy Forbeck Scholar Award Immunotherapies and Mechanisms of Immune Escape (2021).

Career Advancement

1. Instructor Associate. Department of Experimental and Clinical medicine, University of Florence, Florence, Italy. Feb 2022 – Present.

My Bibliography Link

https://www.ncbi.nlm.nih.gov/myncbi/giulia.petroni.1/bibliography/public/